Latest Breaking News On - Nrxp nrx pharmaceuticals - Page 1 : vimarsana.com

NRx Pharmaceuticals, Inc (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024

NRx Pharmaceuticals, Inc (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJonathan javittMatthew duffyNrx pharmaceuticals incPlaza hotelUs national institutes of healthNrxp nrx pharmaceuticalsNrx pharmaceuticalsAnnual global conferenceChief scientistChief business officerBreakthrough therapyNew drug applicationHope therapeuticsFast track designation

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

Both drugs demonstrated > 50% response for treating depression. NRX-101 demonstrated a mean 76% reduction in symptoms of akathisia compared to lurasidone that.

United statesJonathan javittDaniel javittSource nrx pharmaceuticals incUs national institutes of healthExchange commissionTherapeutics incAmerican society of clinical psychopharmacologySpecialty pharmaceutical companyNrx pharmaceuticalsNrxp nrx pharmaceuticalsCompany special protocol agreementPrnewswire nrx pharmaceuticals incSecurities exchangeEffect sizeAmerican society

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan javittAndrew nierenbergNrx pharmaceuticalsAlvogen incNrx pharmaceuticals incNrxp nrx pharmaceuticalsLotus pharmaceuticals incTreatment resistant bipolar depression studyLotus pharmaceuticalsBreakthrough therapy designationFast track designationBiomarker letterSpecial protocol agreementSuicidal treatment resistant bipolarSevere bipolar depression

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMarion leboyerStephen willardMichael grunebaumMocrane abbarJanet rehnquistSecurities exchangeLotus pharmaceuticals incPrnewswire nrx pharmaceuticals incAlvogen incExchange commissionTherapeutics incNephron pharmaceuticals incCompany board of directorsCompany scientific leadership sappko

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

/PRNewswire/ NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announces.

United statesStephen willardTherapeutics incNrx pharmaceuticalsUs national institutes of healthUs patient centered outcomes research initiativeAlvogen incNephron pharmaceuticalsLotus pharmaceuticals incNrxp nrx pharmaceuticalsPrnewswire nrx pharmaceuticals incSpecialty pharmaceutical companyCompany board of directorsLotus pharmaceuticalsSuicidal bipolar depressionData lock